Metastatic colorectal cancer (mCRC): BEVAAS in combination with Fluoropyrimidine-based chemotherapy is indicated for the treatment of patients with metastatic carcinoma of the colon or rectum.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education